| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | 1.91e-05 | 509 | 77 | 10 | GO:0044772 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | RAD51C RAD51B CCNF CENPF POLE DLGAP5 MUS81 SASS6 YWHAQ CDC6 CDK6 | 2.03e-05 | 627 | 77 | 11 | GO:0044770 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | RAD51C RAD51B CCNF CENPF POLE DLGAP5 MUS81 SASS6 YWHAQ CDC6 SPAG5 CDK6 | 7.25e-05 | 854 | 77 | 12 | GO:1903047 |
| GeneOntologyBiologicalProcess | regulation of G2/M transition of mitotic cell cycle | 7.38e-05 | 116 | 77 | 5 | GO:0010389 | |
| GeneOntologyBiologicalProcess | positive regulation of mitotic cell cycle phase transition | 7.69e-05 | 117 | 77 | 5 | GO:1901992 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | 1.26e-04 | 402 | 77 | 8 | GO:1901990 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | 1.28e-04 | 516 | 77 | 9 | GO:1901987 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G2/M phase transition | 1.31e-04 | 131 | 77 | 5 | GO:1902749 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle phase transition | 1.79e-04 | 140 | 77 | 5 | GO:1901989 | |
| GeneOntologyBiologicalProcess | G2/M transition of mitotic cell cycle | 2.62e-04 | 152 | 77 | 5 | GO:0000086 | |
| GeneOntologyBiologicalProcess | positive regulation of mitotic cell cycle | 2.87e-04 | 155 | 77 | 5 | GO:0045931 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | RAD51C RAD51B CCNF CENPF DLGAP5 MUS81 SASS6 YWHAQ CDC6 SPAG5 CDK6 | 2.89e-04 | 845 | 77 | 11 | GO:0010564 |
| GeneOntologyBiologicalProcess | mitotic cell cycle | RAD51C RAD51B CCNF CENPF POLE DLGAP5 MUS81 SASS6 YWHAQ CDC6 SPAG5 CDK6 | 3.58e-04 | 1014 | 77 | 12 | GO:0000278 |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | 3.62e-04 | 594 | 77 | 9 | GO:0007346 | |
| GeneOntologyBiologicalProcess | positive regulation of spindle assembly | 3.80e-04 | 8 | 77 | 2 | GO:1905832 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 4.42e-04 | 95 | 77 | 4 | GO:0030071 | |
| GeneOntologyBiologicalProcess | cell cycle G2/M phase transition | 4.51e-04 | 171 | 77 | 5 | GO:0044839 | |
| GeneOntologyBiologicalProcess | negative regulation of Schwann cell proliferation | 4.87e-04 | 9 | 77 | 2 | GO:0010626 | |
| GeneOntologyBiologicalProcess | mast cell proliferation | 4.87e-04 | 9 | 77 | 2 | GO:0070662 | |
| GeneOntologyBiologicalProcess | regulation of mast cell proliferation | 4.87e-04 | 9 | 77 | 2 | GO:0070666 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 4.97e-04 | 98 | 77 | 4 | GO:1902099 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 5.37e-04 | 100 | 77 | 4 | GO:0007091 | |
| GeneOntologyCellularComponent | Rad51B-Rad51C-Rad51D-XRCC2 complex | 8.42e-05 | 4 | 79 | 2 | GO:0033063 | |
| GeneOntologyCellularComponent | Holliday junction resolvase complex | 1.40e-04 | 5 | 79 | 2 | GO:0048476 | |
| GeneOntologyCellularComponent | endodeoxyribonuclease complex | 2.09e-04 | 6 | 79 | 2 | GO:1905347 | |
| GeneOntologyCellularComponent | DNA recombinase mediator complex | 2.93e-04 | 7 | 79 | 2 | GO:0033061 | |
| GeneOntologyCellularComponent | centrosome | 6.29e-04 | 770 | 79 | 10 | GO:0005813 | |
| GeneOntologyCellularComponent | microtubule organizing center | RABEP2 CCNF TEKT2 CENPF LRRC49 DLGAP5 SASS6 YWHAQ SKI SPAG5 CDK6 | 6.55e-04 | 919 | 79 | 11 | GO:0005815 |
| GeneOntologyCellularComponent | spindle pole | 1.08e-03 | 205 | 79 | 5 | GO:0000922 | |
| Domain | Oest-rel_rcp | 5.15e-05 | 3 | 78 | 2 | IPR027289 | |
| Domain | Oest_rcpt/oest-rel_rcp | 1.71e-04 | 5 | 78 | 2 | IPR024178 | |
| Domain | Rad51_DMC1_RadA | 2.55e-04 | 6 | 78 | 2 | IPR033925 | |
| Domain | DNA_recomb/repair_RecA-like | 2.55e-04 | 6 | 78 | 2 | IPR016467 | |
| Domain | AAA+_ATPase | 3.41e-04 | 144 | 78 | 5 | IPR003593 | |
| Domain | AAA | 3.41e-04 | 144 | 78 | 5 | SM00382 | |
| Domain | 14_3_3 | 3.57e-04 | 7 | 78 | 2 | SM00101 | |
| Domain | 1433_1 | 3.57e-04 | 7 | 78 | 2 | PS00796 | |
| Domain | 1433_2 | 3.57e-04 | 7 | 78 | 2 | PS00797 | |
| Domain | Pept_M16_Zn_BS | 3.57e-04 | 7 | 78 | 2 | IPR001431 | |
| Domain | Pept_M16_dom | 3.57e-04 | 7 | 78 | 2 | IPR011237 | |
| Domain | Metalloenz_LuxS/M16 | 3.57e-04 | 7 | 78 | 2 | IPR011249 | |
| Domain | Peptidase_M16_C | 3.57e-04 | 7 | 78 | 2 | PF05193 | |
| Domain | DNA_recomb/repair_Rad51_C | 3.57e-04 | 7 | 78 | 2 | IPR013632 | |
| Domain | 14-3-3_domain | 3.57e-04 | 7 | 78 | 2 | IPR023410 | |
| Domain | Rad51 | 3.57e-04 | 7 | 78 | 2 | PF08423 | |
| Domain | 14-3-3_CS | 3.57e-04 | 7 | 78 | 2 | IPR023409 | |
| Domain | 14-3-3 | 3.57e-04 | 7 | 78 | 2 | PF00244 | |
| Domain | Pept_M16_N | 3.57e-04 | 7 | 78 | 2 | IPR011765 | |
| Domain | RecA_ATP-bd | 3.57e-04 | 7 | 78 | 2 | IPR020588 | |
| Domain | RECA_2 | 3.57e-04 | 7 | 78 | 2 | PS50162 | |
| Domain | Peptidase_M16 | 3.57e-04 | 7 | 78 | 2 | PF00675 | |
| Domain | - | 3.57e-04 | 7 | 78 | 2 | 3.30.830.10 | |
| Domain | Peptidase_M16_C | 3.57e-04 | 7 | 78 | 2 | IPR007863 | |
| Domain | INSULINASE | 3.57e-04 | 7 | 78 | 2 | PS00143 | |
| Domain | 14-3-3 | 4.74e-04 | 8 | 78 | 2 | IPR000308 | |
| Domain | Tektin | 4.74e-04 | 8 | 78 | 2 | IPR000435 | |
| Domain | Retinoid-X_rcpt/HNF4 | 7.58e-04 | 10 | 78 | 2 | IPR000003 | |
| Domain | VWFA | 4.90e-03 | 82 | 78 | 3 | PS50234 | |
| Domain | VWA | 5.24e-03 | 84 | 78 | 3 | SM00327 | |
| Domain | JMJC | 7.87e-03 | 32 | 78 | 2 | PS51184 | |
| Domain | JmjC_dom | 7.87e-03 | 32 | 78 | 2 | IPR003347 | |
| Domain | VWF_A | 8.25e-03 | 99 | 78 | 3 | IPR002035 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 9.92e-05 | 59 | 58 | 4 | MM15283 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 1.93e-04 | 70 | 58 | 4 | M27570 | |
| Pathway | KEGG_HOMOLOGOUS_RECOMBINATION | 2.01e-04 | 28 | 58 | 3 | M11675 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | 2.14e-04 | 299 | 58 | 7 | MM15711 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | 2.57e-04 | 308 | 58 | 7 | M1070 | |
| Pathway | REACTOME_NEDDYLATION | 3.21e-04 | 226 | 58 | 6 | MM15543 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION | 3.30e-04 | 33 | 58 | 3 | M47842 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 3.94e-04 | 35 | 58 | 3 | MM15293 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 4.65e-04 | 37 | 58 | 3 | M27583 | |
| Pathway | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | 4.92e-04 | 343 | 58 | 7 | MM15712 | |
| Pathway | REACTOME_NEDDYLATION | 4.93e-04 | 245 | 58 | 6 | M27822 | |
| Pubmed | 1.74e-08 | 13 | 79 | 4 | 7626882 | ||
| Pubmed | Expression of estrogen-related receptors in ovarian cancer and impact on survival. | 5.09e-06 | 2 | 79 | 2 | 34089362 | |
| Pubmed | Genome-wide association study identifies two risk loci for tuberculosis in Han Chinese. | 5.09e-06 | 2 | 79 | 2 | 30287856 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 16596631 | ||
| Pubmed | Characterization of zetin 1/rBSPRY, a novel binding partner of 14-3-3 proteins. | 5.09e-06 | 2 | 79 | 2 | 12615066 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 16271875 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 10072763 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 19631715 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 32668300 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RLF DNAJC13 NF1 PMPCB POLE PSMB1 DLGAP5 FERMT1 AP1G2 CHD8 UQCRC1 YWHAQ YWHAZ | 1.07e-05 | 1353 | 79 | 13 | 29467282 |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 12409258 | ||
| Pubmed | The HsRAD51B-HsRAD51C stabilizes the HsRAD51 nucleoprotein filament. | 1.53e-05 | 3 | 79 | 2 | 23810717 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 11945020 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 26699812 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 29888756 | ||
| Pubmed | Regulation of the Water Channel Aquaporin-2 via 14-3-3θ and -ζ. | 1.53e-05 | 3 | 79 | 2 | 26645691 | |
| Pubmed | Molecular dynamics and in vitro analysis of Connexin43: A new 14-3-3 mode-1 interacting protein. | 1.53e-05 | 3 | 79 | 2 | 17008717 | |
| Pubmed | Mediator function of the human Rad51B-Rad51C complex in Rad51/RPA-catalyzed DNA strand exchange. | 1.53e-05 | 3 | 79 | 2 | 11751636 | |
| Pubmed | Complex formation by the human Rad51B and Rad51C DNA repair proteins and their activities in vitro. | 1.53e-05 | 3 | 79 | 2 | 12427746 | |
| Pubmed | Sequential role of RAD51 paralog complexes in replication fork remodeling and restart. | 1.53e-05 | 3 | 79 | 2 | 32669601 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 20679480 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 15598686 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 16874310 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 9360956 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 26261251 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 22575644 | ||
| Pubmed | A hot spot for RAD51C interactions revealed by a peptide that sensitizes cells to cisplatin. | 1.53e-05 | 3 | 79 | 2 | 15126333 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 12118380 | ||
| Pubmed | Dysregulated 14-3-3 Family in Peripheral Blood Leukocytes of Patients with Schizophrenia. | 1.53e-05 | 3 | 79 | 2 | 27030512 | |
| Pubmed | Variation within DNA repair pathway genes and risk of multiple sclerosis. | 2.26e-05 | 72 | 79 | 4 | 20522537 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 17920809 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 22010828 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 24269678 | ||
| Pubmed | Structural insights into BCDX2 complex function in homologous recombination. | 3.05e-05 | 4 | 79 | 2 | 37344589 | |
| Pubmed | Structure and function of the RAD51B-RAD51C-RAD51D-XRCC2 tumour suppressor. | 3.05e-05 | 4 | 79 | 2 | 37344587 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 15650334 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 18059471 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 16822840 | ||
| Pubmed | Involvement of 14-3-3 proteins in nuclear localization of telomerase. | 3.05e-05 | 4 | 79 | 2 | 10835362 | |
| Pubmed | Isolation and characterization of RAD51C, a new human member of the RAD51 family of related genes. | 3.05e-05 | 4 | 79 | 2 | 9469824 | |
| Pubmed | CPAP interacts with 14-3-3 in a cell cycle-dependent manner. | 3.05e-05 | 4 | 79 | 2 | 16516142 | |
| Pubmed | The RAD51 paralogs ensure cellular protection against mitotic defects and aneuploidy. | 3.05e-05 | 4 | 79 | 2 | 23108668 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 18039682 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 27737800 | ||
| Pubmed | 14-3-3zeta/tau heterodimers regulate Slingshot activity in migrating keratinocytes. | 3.05e-05 | 4 | 79 | 2 | 19371722 | |
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 29940916 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 20308060 | ||
| Pubmed | 4.74e-05 | 418 | 79 | 7 | 34709266 | ||
| Pubmed | Interactions involving the Rad51 paralogs Rad51C and XRCC3 in human cells. | 5.07e-05 | 5 | 79 | 2 | 11842112 | |
| Pubmed | SCF(Cyclin F)-dependent degradation of CDC6 suppresses DNA re-replication. | 5.07e-05 | 5 | 79 | 2 | 26818844 | |
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 18509053 | ||
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 14970201 | ||
| Pubmed | Isoform-specific cleavage of 14-3-3 proteins in apoptotic JURL-MK1 cells. | 5.07e-05 | 5 | 79 | 2 | 19173300 | |
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 14704354 | ||
| Pubmed | The Cdk-like protein PCTAIRE-1 from mouse brain associates with p11 and 14-3-3 proteins. | 5.07e-05 | 5 | 79 | 2 | 9197417 | |
| Pubmed | Identification and purification of two distinct complexes containing the five RAD51 paralogs. | 5.07e-05 | 5 | 79 | 2 | 11751635 | |
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 11985497 | ||
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 12944463 | ||
| Pubmed | Integration of calcium and cyclic AMP signaling pathways by 14-3-3. | 5.07e-05 | 5 | 79 | 2 | 10611249 | |
| Pubmed | Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control. | 5.07e-05 | 5 | 79 | 2 | 25557911 | |
| Pubmed | ARF6 GTPase protects the post-mitotic midbody from 14-3-3-mediated disintegration. | 5.07e-05 | 5 | 79 | 2 | 22580824 | |
| Pubmed | Aurora B and 14-3-3 coordinately regulate clustering of centralspindlin during cytokinesis. | 5.07e-05 | 5 | 79 | 2 | 20451386 | |
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 24351927 | ||
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 12975363 | ||
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 9804998 | ||
| Pubmed | Nuclear receptor/microRNA circuitry links muscle fiber type to energy metabolism. | 5.07e-05 | 5 | 79 | 2 | 23676496 | |
| Pubmed | RAD51C interacts with RAD51B and is central to a larger protein complex in vivo exclusive of RAD51. | 5.07e-05 | 5 | 79 | 2 | 11744692 | |
| Pubmed | 5.86e-05 | 33 | 79 | 3 | 19714462 | ||
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 28864920 | ||
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 15163635 | ||
| Pubmed | Involvement of Rad51C in two distinct protein complexes of Rad51 paralogs in human cells. | 7.60e-05 | 6 | 79 | 2 | 11842113 | |
| Pubmed | 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. | 7.60e-05 | 6 | 79 | 2 | 11864996 | |
| Pubmed | Parkin degrades estrogen-related receptors to limit the expression of monoamine oxidases. | 7.60e-05 | 6 | 79 | 2 | 21177257 | |
| Pubmed | C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. | 7.60e-05 | 6 | 79 | 2 | 9543386 | |
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 20207730 | ||
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 23836911 | ||
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 19933840 | ||
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 17389761 | ||
| Pubmed | Identification of a novel interaction of 14-3-3 with p190RhoGEF. | 7.60e-05 | 6 | 79 | 2 | 11533041 | |
| Pubmed | The interaction between casein kinase Ialpha and 14-3-3 is phosphorylation dependent. | 7.60e-05 | 6 | 79 | 2 | 19860830 | |
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 16439465 | ||
| Pubmed | Specific interaction between 14-3-3 isoforms and the human CDC25B phosphatase. | 7.60e-05 | 6 | 79 | 2 | 10713667 | |
| Pubmed | Uncoupling proteins 2 and 3 interact with members of the 14.3.3 family. | 7.60e-05 | 6 | 79 | 2 | 10785390 | |
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 10441394 | ||
| Pubmed | Inhibitory interaction of the plasma membrane Na+/Ca2+ exchangers with the 14-3-3 proteins. | 1.06e-04 | 7 | 79 | 2 | 16679322 | |
| Pubmed | Interaction of apoptosis signal-regulating kinase 1 with isoforms of 14-3-3 proteins. | 1.06e-04 | 7 | 79 | 2 | 15023544 | |
| Pubmed | The expression of seven 14-3-3 isoforms in human meningioma. | 1.06e-04 | 7 | 79 | 2 | 20388496 | |
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 37243816 | ||
| Pubmed | CCM3/PDCD10 stabilizes GCKIII proteins to promote Golgi assembly and cell orientation. | 1.06e-04 | 7 | 79 | 2 | 20332113 | |
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 15065660 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 22588126 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 12853467 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 23149936 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 10620507 | ||
| Pubmed | A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo. | 1.06e-04 | 7 | 79 | 2 | 12383250 | |
| Pubmed | Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins. | 1.06e-04 | 7 | 79 | 2 | 36096339 | |
| Pubmed | The cyclin-dependent kinase 11 interacts with 14-3-3 proteins. | 1.06e-04 | 7 | 79 | 2 | 15883043 | |
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 16868027 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 31906564 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 9092538 | ||
| Interaction | E2F8 interactions | 1.97e-06 | 24 | 77 | 4 | int:E2F8 | |
| Interaction | SAMD4B interactions | 7.26e-06 | 122 | 77 | 6 | int:SAMD4B | |
| GeneFamily | Tektins | 7.16e-05 | 5 | 49 | 2 | 949 | |
| GeneFamily | 14-3-3 phospho-serine/phospho-threonine binding proteins | 1.50e-04 | 7 | 49 | 2 | 1053 | |
| GeneFamily | Keratins, type I | 2.60e-03 | 28 | 49 | 2 | 608 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | RAD51C CCNF METAP1 NF1 CENPF POLE DLGAP5 HMGCR ATP13A3 CDC6 THAP12 SPAG5 | 2.84e-06 | 761 | 79 | 12 | M11961 |
| Coexpression | WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53 | 4.27e-06 | 11 | 79 | 3 | M6312 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 5.48e-06 | 426 | 79 | 9 | M9516 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | CCNF CENPF POLE DLGAP5 SASS6 ANKRD24 CDC6 THAP12 PDZRN3 SPAG5 | 9.25e-06 | 578 | 79 | 10 | M2368 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | CCNF CENPF POLE DLGAP5 SASS6 ANKRD24 CDC6 THAP12 PDZRN3 SPAG5 | 1.22e-05 | 597 | 79 | 10 | MM1309 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 2.88e-05 | 402 | 79 | 8 | MM454 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP | 3.20e-05 | 200 | 79 | 6 | M5041 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | 5.38e-05 | 322 | 79 | 7 | M39060 | |
| Coexpression | ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER | 6.64e-05 | 140 | 79 | 5 | M15664 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_UP | 1.01e-04 | 153 | 79 | 5 | M18058 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | 2.89e-06 | 422 | 77 | 10 | GSM538355_500 | |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | 1.98e-05 | 417 | 77 | 9 | GSM399403_500 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | 2.05e-05 | 419 | 77 | 9 | GSM538348_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | 9.50e-05 | 397 | 77 | 8 | GSM791143_500 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | 9.84e-05 | 399 | 77 | 8 | GSM538345_500 | |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2 | 1.02e-04 | 401 | 77 | 8 | GSM399450_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_500 | 1.03e-04 | 67 | 77 | 4 | gudmap_developingGonad_e18.5_epididymis_500_k3 | |
| CoexpressionAtlas | Stem Cells, SC.MDP.BM, Sca1- Flt3+ MCSFR+ cKithi, Bone marrow, avg-3 | 1.04e-04 | 402 | 77 | 8 | GSM791105_500 | |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 1.17e-04 | 409 | 77 | 8 | GSM399452_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 1.19e-04 | 410 | 77 | 8 | GSM538387_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3 | 1.27e-04 | 414 | 77 | 8 | GSM476660_500 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | 1.36e-04 | 418 | 77 | 8 | GSM538350_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN2-3.Th, Lin-/lo CD25hi CD44Int, Thymus, avg-2 | 2.36e-04 | 83 | 77 | 4 | GSM791134_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.Th, TCRd+ CD3e+, Thymus, avg-3 | 2.74e-04 | 349 | 77 | 7 | GSM476675_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3B.Th, Lin-/lo CD25hi CD44- CD28+, Thymus, avg-3 | 2.83e-04 | 87 | 77 | 4 | GSM791149_100 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 3.22e-04 | 90 | 77 | 4 | GSM399397_100 | |
| CoexpressionAtlas | alpha beta T cells, T.8.TI.B16, 4- 8+ TCR+ 45+, B16 Melanoma Tumor, avg-2 | 3.25e-04 | 359 | 77 | 7 | GSM605773_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.50e-04 | 258 | 77 | 6 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3 | 4.08e-04 | 373 | 77 | 7 | GSM605781_500 | |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-1 | 4.28e-04 | 376 | 77 | 7 | GSM538418_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500 | 4.29e-04 | 97 | 77 | 4 | gudmap_developingGonad_e18.5_ovary_500_k3 | |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | 5.16e-04 | 388 | 77 | 7 | GSM538352_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_500 | 5.83e-04 | 45 | 77 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k3 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 6.01e-04 | 398 | 77 | 7 | GSM399397_500 | |
| CoexpressionAtlas | Stem Cells, SC.CDP.BM, Sca1- Flt3+ MCSFR+ cKitlo, Bone marrow, avg-3 | 6.28e-04 | 401 | 77 | 7 | GSM791114_500 | |
| CoexpressionAtlas | Stem Cells, SC.MPP34F.BM, Lineage- cKit+ Sca-1+ flk2+ CD34+, Bone marrow, avg-2 | 6.28e-04 | 401 | 77 | 7 | GSM791110_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_500 | 6.67e-04 | 109 | 77 | 4 | gudmap_developingGonad_e16.5_ovary_500_k5 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th.TCRbko, TCRd+ Vg2+ CD24+, Thymus, avg-3 | 7.36e-04 | 412 | 77 | 7 | GSM605793_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3B.Th, Lin-/lo CD25hi CD44- CD28+, Thymus, avg-3 | 7.47e-04 | 413 | 77 | 7 | GSM791149_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN2-3.Th, Lin-/lo CD25hi CD44Int, Thymus, avg-2 | 7.68e-04 | 415 | 77 | 7 | GSM791134_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN2B.Th, Lin-/lo CD25hi CD44+ cKitint, Thymus, avg-2 | 8.24e-04 | 420 | 77 | 7 | GSM791141_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | 8.47e-04 | 422 | 77 | 7 | GSM476658_500 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | 8.47e-04 | 422 | 77 | 7 | GSM538357_500 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.08e-08 | 153 | 79 | 7 | d7635f3d4831c02a94f53afc674847d5b51453be | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.08e-08 | 153 | 79 | 7 | 54a941950bbb848077c7bd5726da9e4b3244bd38 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.08e-08 | 153 | 79 | 7 | 69a8550418ba0fc908a84b3b85761abb6e8ca4c0 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P4-Tnr-Polydendrocyte.Tnr.Dlx1_(Dlx1)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.08e-08 | 153 | 79 | 7 | e50d20f9e553b8c3e10e187770d8abe1a43d109e | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.64e-08 | 189 | 79 | 7 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.54e-08 | 194 | 79 | 7 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.16e-08 | 197 | 79 | 7 | 0b1fa881abbfcc54b322fc27124db3f8947af016 | |
| ToppCell | proximal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.16e-08 | 197 | 79 | 7 | 0dd9058aa19d1268ebba9a65555870224b5a5978 | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.16e-08 | 197 | 79 | 7 | 9243617b307acf3df40d93c41cd8d4788699a7ea | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.60e-08 | 199 | 79 | 7 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 6.83e-08 | 200 | 79 | 7 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|bone_marrow / Manually curated celltypes from each tissue | 6.31e-07 | 172 | 79 | 6 | a66402d15853f0c9e3d06394ff9ac08d1da128ff | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.50e-07 | 181 | 79 | 6 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.50e-07 | 181 | 79 | 6 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-06 | 191 | 79 | 6 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.16e-06 | 191 | 79 | 6 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-06 | 191 | 79 | 6 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | (3)_Macrophage_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.16e-06 | 191 | 79 | 6 | b42f0b89bb94fd43786ff50f1caeb3ebfbbb43fd | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-06 | 192 | 79 | 6 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-06 | 194 | 79 | 6 | 3a49c7c86036e09a8cd0114988380d04ad1a26fb | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-06 | 195 | 79 | 6 | 5790b47b0e028e49b99bda8d6d9e80ac79208cdf | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.43e-06 | 198 | 79 | 6 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | TCGA-Lung-Primary_Tumor|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.48e-06 | 199 | 79 | 6 | d1d035e987280607266171094db5d6362efe1ad5 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.48e-06 | 199 | 79 | 6 | 88d130e2451e61afb710edf552e6b346b9fcfb2b | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.48e-06 | 199 | 79 | 6 | 6748d4f76703360071d5f2026d9d06bf30ccfb6d | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.52e-06 | 200 | 79 | 6 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | LAM-Myeloid-pMacrophage|Myeloid / Condition, Lineage and Cell class | 1.52e-06 | 200 | 79 | 6 | 0078d56337d44074326e8ccd1d412d098d86eeab | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-T/NK_proliferative|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.52e-06 | 200 | 79 | 6 | 7faf1e37364203a08d2b2544979e848b41e36b1c | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.52e-06 | 200 | 79 | 6 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | LAM-Myeloid-pMacrophage|LAM / Condition, Lineage and Cell class | 1.52e-06 | 200 | 79 | 6 | 7e233d037165c9d3607604aaaf0f368e266567d3 | |
| ToppCell | Biopsy_Other_PF-Immune-Proliferating_Macrophages|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.52e-06 | 200 | 79 | 6 | 61473e8613f39a92002d5b631e6bd563735566e4 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.52e-06 | 200 | 79 | 6 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.52e-06 | 200 | 79 | 6 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.52e-06 | 200 | 79 | 6 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-06 | 116 | 79 | 5 | df7609503782d8d7e4f31ed2a626916e5474d5bc | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-06 | 121 | 79 | 5 | e82c9e10b98c8d7ad828cf8ac19a2342014be2ba | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.11e-06 | 134 | 79 | 5 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-DN4_thymocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.89e-06 | 149 | 79 | 5 | 89faa84af68d4727180f39718964bb3bc65d8fe6 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.00e-05 | 161 | 79 | 5 | 0dd1401b4c990d49fccb702a9f9867590a58e203 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.00e-05 | 161 | 79 | 5 | b6a31c033edc74f23a20aab1f18e80cc83ffee4c | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.00e-05 | 161 | 79 | 5 | efb811dda4d73107983a5f68302bdcf4f408d5b4 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.00e-05 | 161 | 79 | 5 | 28d5dbd20c9f8e0069f172d552997a044790e1a7 | |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.27e-05 | 169 | 79 | 5 | eb0c993ef2eea73bc4881182520922ce9ae9368f | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-05 | 171 | 79 | 5 | 05014cf6746e6663e376fdd681f1b43a7081c603 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-05 | 171 | 79 | 5 | d6114db2292fbb27b39d090d51fd305a135b1ccf | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-05 | 173 | 79 | 5 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-05 | 173 | 79 | 5 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-05 | 174 | 79 | 5 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-05 | 174 | 79 | 5 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-05 | 174 | 79 | 5 | 6c36d607c48267a75ab4da6fb2fe3f931d1b3b52 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.54e-05 | 176 | 79 | 5 | d70fdc7bc48719776ed1e7c01118385e3a21623f | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.54e-05 | 176 | 79 | 5 | a84361308e5e96f3a30246cd29e109c321ee65bf | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-05 | 177 | 79 | 5 | 3e149bff1f1b393a7abe98984e37981c8296f95d | |
| ToppCell | NS-moderate-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.59e-05 | 177 | 79 | 5 | 174c54acfe19e2bb31418d69e228032ba724cbb6 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-05 | 180 | 79 | 5 | 40d4838a0ccb10d5e49266bc8a0037d27b75ccc2 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 180 | 79 | 5 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.77e-05 | 181 | 79 | 5 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 182 | 79 | 5 | bc6a120dedc813c58baac1428c39851a07b71ba7 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-05 | 182 | 79 | 5 | 818b5155ec81f0059048d6070a108116ecd72e3c | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 1.81e-05 | 182 | 79 | 5 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 182 | 79 | 5 | 0fc45214f0b0766f69be6eff69cc4bec574023aa | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.86e-05 | 183 | 79 | 5 | df8568751205313d149939ea2683097e3652a60b | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.91e-05 | 184 | 79 | 5 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.96e-05 | 185 | 79 | 5 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 187 | 79 | 5 | a2076599b33ae6750961b573bfebcb9036fa4ee8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 187 | 79 | 5 | 38ee33295a21db4aae5ba085df033db9693e41c6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 187 | 79 | 5 | dbcec24d2c852964736c78e9d81650bff5c455ae | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.12e-05 | 188 | 79 | 5 | 6c05797a5d0635d89ffcf4aca52178687129ccb4 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 189 | 79 | 5 | bfa3ed1360991a3e32fad133017c413f8adc1eba | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 189 | 79 | 5 | 96f10c63656e446b4bb712f012e91ae986f8c2d0 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 2.17e-05 | 189 | 79 | 5 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.17e-05 | 189 | 79 | 5 | c8b8f860aaf6c73863cd79941db6b469c830ef06 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 2.23e-05 | 190 | 79 | 5 | 165c61443ff0c8efbdad3b052bb00f46d81c5203 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 2.23e-05 | 190 | 79 | 5 | 451eaceb0cb0ec6cfcae00253c0e5c92a168c2f3 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-NK-Cycling_NK|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.29e-05 | 191 | 79 | 5 | 5d4fed25bd318472a17228b12ade4c331865bda5 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-05 | 191 | 79 | 5 | d6e158f16a183c9203c057192342e9b83e79bc89 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-05 | 191 | 79 | 5 | 7cb5c6f2cf27f3503d1b313e402a7410dfe6473e | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.29e-05 | 191 | 79 | 5 | a2c235a55094e4fd5273d764c9e2967116b48c23 | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 2.29e-05 | 191 | 79 | 5 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 2.40e-05 | 193 | 79 | 5 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.40e-05 | 193 | 79 | 5 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|normal_Lymph_Node / Location, Cell class and cell subclass | 2.40e-05 | 193 | 79 | 5 | 5ce93860bc60ce6ecfed3a3d985f84e28781eec1 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-05 | 194 | 79 | 5 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.46e-05 | 194 | 79 | 5 | 22bcfb0f3f73608feb22c0847ab4d34f87aeede0 | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.46e-05 | 194 | 79 | 5 | 5e56ce9b9fe0721be3a9e6efe1422599bb867721 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.46e-05 | 194 | 79 | 5 | 3590ff471f74a361ee5bf02a58e3104cd3bf7d00 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.46e-05 | 194 | 79 | 5 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 2.46e-05 | 194 | 79 | 5 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.46e-05 | 194 | 79 | 5 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 2.46e-05 | 194 | 79 | 5 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.46e-05 | 194 | 79 | 5 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-05 | 194 | 79 | 5 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-05 | 194 | 79 | 5 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 | |
| ToppCell | control-Lymphocytic-Prol._cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.46e-05 | 194 | 79 | 5 | 4c76508de3291c952386caffda2d559629ba5998 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.46e-05 | 194 | 79 | 5 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.52e-05 | 195 | 79 | 5 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.52e-05 | 195 | 79 | 5 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 195 | 79 | 5 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | Influenza_Severe-T/NK_proliferative|World / Disease group and Cell class | 2.52e-05 | 195 | 79 | 5 | 6f079c2d7d08110a5e1822ea861b8037eb3f62c9 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.52e-05 | 195 | 79 | 5 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; HL60; HT_HG-U133A | 4.04e-06 | 190 | 78 | 7 | 1334_DN | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; PC3; HT_HG-U133A | 4.64e-06 | 194 | 78 | 7 | 6741_UP | |
| Drug | Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; HL60; HT_HG-U133A | 4.80e-06 | 195 | 78 | 7 | 1273_UP | |
| Drug | N'-((1E)-(4-(diethylamino)phenyl)methylene)-4-hydroxybenzohydrazide | 1.16e-05 | 2 | 78 | 2 | ctd:C501618 | |
| Disease | multiple mitochondrial dysfunctions syndrome 6 (implicated_via_orthology) | 6.55e-06 | 2 | 76 | 2 | DOID:0070332 (implicated_via_orthology) | |
| Disease | late onset Parkinson's disease (implicated_via_orthology) | 1.96e-05 | 3 | 76 | 2 | DOID:0060892 (implicated_via_orthology) | |
| Disease | platelet crit | RAD51B METAP1 FBXL16 NF1 CHRDL1 HMGCR UQCRC1 KDM6B SKI CCDC40 CDK6 | 3.14e-05 | 952 | 76 | 11 | EFO_0007985 |
| Disease | liposarcoma | 9.75e-05 | 6 | 76 | 2 | C0023827 | |
| Disease | dementia (is_implicated_in) | 4.25e-04 | 12 | 76 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | Autosomal recessive primary microcephaly | 6.73e-04 | 15 | 76 | 2 | cv:C3711387 | |
| Disease | Moyamoya Disease | 8.68e-04 | 17 | 76 | 2 | C0026654 | |
| Disease | intellectual disability (implicated_via_orthology) | 9.70e-04 | 75 | 76 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | lingual gyrus volume measurement | 1.09e-03 | 19 | 76 | 2 | EFO_0010314 | |
| Disease | Chronic myeloproliferative disorder | 1.09e-03 | 19 | 76 | 2 | C1292778 | |
| Disease | Seckel syndrome | 1.46e-03 | 22 | 76 | 2 | C0265202 | |
| Disease | Autosomal Recessive Primary Microcephaly | 1.46e-03 | 22 | 76 | 2 | C3711387 | |
| Disease | azoospermia (implicated_via_orthology) | 2.20e-03 | 27 | 76 | 2 | DOID:14227 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VESELRSICTTVLEL | 86 | P27348 | |
| CEEDIDQILLRRTTT | 1326 | Q9HCK8 | |
| RAAIKDCEVVLLRTT | 61 | Q9H7F0 | |
| VSDICKILNIRRSEE | 121 | Q9BQL6 | |
| VVECLRETDASLSRR | 351 | O75843 | |
| VVRLFDVCTVSRTDR | 76 | Q00534 | |
| RAELERERVCSVALS | 951 | Q8TF21 | |
| VECLSSEEVSLIRRI | 331 | Q8TAM1 | |
| RELTCDEVLQRIESL | 181 | O15315 | |
| EALETLQIIRRECLT | 56 | O43502 | |
| ELRSIELECLSIVRA | 691 | Q9UPQ7 | |
| REETEVLEASLCSLR | 471 | Q9H5N1 | |
| ITAGRIDREELCETV | 86 | Q9Y5H2 | |
| CGIRTRVVSEETLLF | 76 | Q86WS3 | |
| DRDTILVSFERCVRI | 711 | Q12851 | |
| LVRELTVCSSSEEQR | 571 | Q8N1W1 | |
| RLSCLEEERLLLVVT | 576 | P35228 | |
| RIDAVNAETIREVCT | 441 | O75439 | |
| LLVTDTGCEILTRRL | 361 | P53582 | |
| DVLSSDIIILTITRC | 56 | P04035 | |
| RVRDLICTEITPVDA | 31 | Q6ZVZ8 | |
| EISRACETLVERVGR | 916 | O15054 | |
| CITRITTAIRETESI | 61 | Q14D04 | |
| DQRIRVTSEVLTCIK | 336 | Q96J66 | |
| RVLDELTLCRTDLEI | 196 | Q7Z3Y8 | |
| LTLCRTDLEIQLETL | 201 | Q7Z3Y8 | |
| RVLDEITLCRTDLEI | 191 | Q7Z3Z0 | |
| IEEISGLSTLRCLRV | 146 | Q8IUZ0 | |
| ELDCQLTRDRVVVVS | 71 | Q7L5L3 | |
| RRVAVESAEACLIIA | 401 | A8MYU2 | |
| LSEVESLRLEAICDI | 436 | Q6NSJ5 | |
| ETDEELRRRQLTCTE | 91 | Q15599 | |
| ITKVEERLTTICQRE | 736 | Q07864 | |
| LRLDSLDIESERTVC | 226 | Q8WVZ9 | |
| ITLGVRILDTCSRDT | 96 | O00222 | |
| RLTDSCVQRLLEITE | 51 | Q86U28 | |
| SRIAEVDASVVREIC | 431 | P31930 | |
| TIREGETLELTCLVT | 51 | Q7Z553 | |
| LAEVLREVTCRSKEL | 951 | Q7Z442 | |
| LSERTVEIILSVTLC | 1941 | Q9UMZ3 | |
| ICESCIREETLREVR | 241 | O43422 | |
| ESATLRCTIDDRVTR | 51 | Q14982 | |
| CRTSEVVEIQALRTD | 336 | Q96EW2 | |
| IQRLSLVRSLCESEE | 111 | Q5W0U4 | |
| LVRSLCESEEQRLLE | 116 | Q5W0U4 | |
| IVCLEEELSVVTSER | 1946 | P49454 | |
| VICTRFISKEILTIR | 361 | P41002 | |
| SSRVCRTELEDLVKV | 431 | Q9BU40 | |
| VVESLTRTLCSRVEE | 326 | Q05707 | |
| TRTLCSRVEEQDREI | 331 | Q05707 | |
| TTLCDLADRELVVII | 266 | P62508 | |
| DLCRIRESVSEELLQ | 81 | O43909 | |
| IDTLCAVLERDTLSI | 221 | Q9H0C5 | |
| AFSDVLVRCEVSRVL | 261 | P23610 | |
| TRILRKAVSEACTEI | 471 | Q4G0X9 | |
| ACTEIDAISVEKRRI | 481 | Q4G0X9 | |
| IEITVSCRNLLDLDT | 16 | Q8IYJ1 | |
| LEELVSSRERAICAL | 51 | O60519 | |
| RIRQEECAETAVSVI | 586 | Q15398 | |
| LDVCRRAIEIVESDV | 391 | Q99741 | |
| VKRVLALTETCLVER | 251 | O75165 | |
| TTLCDLADRELVVII | 241 | O95718 | |
| VLSLRRENSTLDVEC | 296 | Q6UVJ0 | |
| LRICIVTKEGIREET | 221 | P20618 | |
| ELVLDRCVRITDTGL | 376 | Q8N461 | |
| LSAEVRVCTVLARET | 201 | Q6P1K8 | |
| LCRRLDEATLDVITV | 2181 | Q5T011 | |
| ECQLKTTLEVLRERS | 821 | Q96R06 | |
| DVLEITILEIRRDVC | 1661 | O60522 | |
| LSTLEESVVRICCIR | 756 | Q9UPR3 | |
| DVAIECLTLRESRRD | 111 | Q9UIF3 | |
| CLTLRESRRDIDVVK | 116 | Q9UIF3 | |
| LRVLVDCILRDTSED | 266 | Q8WW24 | |
| RSTERCETVLEGETI | 96 | P12755 | |
| IETELRDICNDVLSL | 86 | P63104 | |
| CNSVELIRERLTVSE | 166 | Q96CW6 | |
| DVSILDTTRLLRSCV | 3526 | Q63HN8 | |
| DELERVRVSCTIIFL | 371 | Q9BSA9 | |
| TTECEDVLLVLGRLV | 116 | Q13129 | |
| LSAEVRVCTVLARET | 201 | Q13888 | |
| LDCLDSRRTVRVVAS | 91 | Q71H61 | |
| LDEVLRTLVTSCFLV | 261 | P42226 | |
| GTILVTEEELSRCIE | 441 | Q9C0B7 | |
| RISTRLQELTVCSED | 156 | P21359 | |
| ALLTVSEEVRSRCSL | 2441 | P21359 | |
| ADRSRTSILIICILI | 206 | P0DMS9 | |
| TLELSRALDCEEILI | 41 | O95932 | |
| IVERKRLDDLCSSII | 331 | Q96NY9 |